The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

Subjects:

Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session. by Cristina Dolciotti (16317330)

Middle cerebral artery mean flow velocity at three time points. by Marco Carbonara (11483575)

Subjects:

PAP I point mutations lead to a decrease in pYV PCN, plasmid stability, and T3SS activity. by Katherine Schubert (5452712)

Mean standard errors across time points for the outcome of social stigma. by Ana Beato (20489933)

Means with standard errors across time points for the outcome of social distance. by Ana Beato (20489933)

Means with standard errors across time points for the outcome of intergroup anxiety. by Ana Beato (20489933)

Stable isotope biplots of end-members (colored points) faceted by coastscape and overlayed consumers (gray points). by Nathan D. McTigue (10706460)

Means with standard errors across time points for the outcome of mental health knowledge. by Ana Beato (20489933)

Feasibility diagram of design points. by Xueyong Pan (20390363)

mAP0.5 Curves of various models. by Yaojun Zhang (389482)

“…Results on a specialized dataset reveal that YOLOv8n-BWG outperforms YOLOv8n by increasing the mean Average Precision (mAP) by 4.2%, boosting recognition speed by 21.3% per second, and decreasing both the number of floating-point operations (FLOPs) by 28.9% and model size by 26.3%. …”

Table 1_Subjective spatial orientation discomfort is associated with decreased real-world spatial performance and lower cognitive function.docx by Johannes Gerb (10287758)

Sample points and numerical simulation results. by Xueyong Pan (20390363)

Point cloud fusion instance effect. by Hongliang Zou (20707270)

Subjects:

Mean lesion depth of the SDF test groups and the SDF-free group at baseline and post-cycling time points. by Suphanida Kaewkamchai (19762172)

Mean mineral density of the SDF test groups and the SDF-free group at baseline and post-cycling time points. by Suphanida Kaewkamchai (19762172)

Naringenin decreases total cell viability. by Lauren A. Eanes (20995499)

Scatterplots of IOP at different time points. by Joanna Konopińska (11478391)

Key discussion points. by Monnaphat Jongdeepaisal (10664812)

Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects: